Free Trial

Surgery Partners, Inc. (NASDAQ:SGRY) Shares Sold by Wellington Management Group LLP

Surgery Partners logo with Medical background

Wellington Management Group LLP trimmed its position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 5.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,846,001 shares of the company's stock after selling 617,585 shares during the period. Wellington Management Group LLP owned 7.75% of Surgery Partners worth $317,435,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Arizona State Retirement System boosted its holdings in shares of Surgery Partners by 1.9% in the 2nd quarter. Arizona State Retirement System now owns 19,494 shares of the company's stock valued at $464,000 after acquiring an additional 359 shares during the last quarter. Natixis Advisors LLC lifted its position in Surgery Partners by 3.0% during the third quarter. Natixis Advisors LLC now owns 12,828 shares of the company's stock valued at $414,000 after purchasing an additional 376 shares during the period. KBC Group NV boosted its holdings in Surgery Partners by 31.8% in the third quarter. KBC Group NV now owns 2,385 shares of the company's stock valued at $77,000 after purchasing an additional 576 shares during the last quarter. Mackenzie Financial Corp grew its position in Surgery Partners by 3.4% during the 2nd quarter. Mackenzie Financial Corp now owns 19,999 shares of the company's stock worth $476,000 after purchasing an additional 662 shares during the period. Finally, MeadowBrook Investment Advisors LLC raised its stake in shares of Surgery Partners by 15.9% during the 2nd quarter. MeadowBrook Investment Advisors LLC now owns 12,320 shares of the company's stock valued at $293,000 after buying an additional 1,690 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Royal Bank of Canada lowered their target price on Surgery Partners from $49.00 to $35.00 and set an "outperform" rating on the stock in a research note on Wednesday, November 20th. KeyCorp assumed coverage on shares of Surgery Partners in a research note on Friday, October 11th. They set a "sector weight" rating on the stock. Benchmark reiterated a "buy" rating and issued a $50.00 target price on shares of Surgery Partners in a research note on Monday, August 26th. JPMorgan Chase & Co. lowered their price target on shares of Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a report on Tuesday, December 3rd. Finally, Macquarie reaffirmed an "outperform" rating and issued a $34.00 price objective on shares of Surgery Partners in a report on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Surgery Partners presently has a consensus rating of "Moderate Buy" and a consensus target price of $37.38.

Read Our Latest Stock Report on SGRY

Surgery Partners Price Performance

Shares of NASDAQ SGRY traded up $0.43 during trading on Friday, hitting $21.89. The company had a trading volume of 1,373,440 shares, compared to its average volume of 1,453,903. Surgery Partners, Inc. has a fifty-two week low of $21.10 and a fifty-two week high of $36.92. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. The stock has a fifty day simple moving average of $28.00 and a two-hundred day simple moving average of $28.12. The firm has a market capitalization of $2.78 billion, a price-to-earnings ratio of -45.60, a price-to-earnings-growth ratio of 18.75 and a beta of 2.58.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). The firm had revenue of $770.40 million for the quarter, compared to analysts' expectations of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. Surgery Partners's quarterly revenue was up 14.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.15 earnings per share. On average, research analysts expect that Surgery Partners, Inc. will post 0.73 earnings per share for the current year.

About Surgery Partners

(Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Featured Stories

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Should you invest $1,000 in Surgery Partners right now?

Before you consider Surgery Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.

While Surgery Partners currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines